In the last trading session, 2.21 million Transmedics Group Inc (NASDAQ:TMDX) shares changed hands as the company’s beta touched 2.12. With the company’s per share price at $73.00 changed hands at -$4.12 or -5.34% during last session, the market valuation stood at $2.45B. TMDX’s last price was a discount, traded about -142.97% off its 52-week high of $177.37. The share price had its 52-week low at $55.00, which suggests the last value was 24.66% up since then.
Analysts gave the Transmedics Group Inc (TMDX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.70. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended TMDX as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Transmedics Group Inc’s EPS for the current quarter is expected to be 0.15.
Transmedics Group Inc (NASDAQ:TMDX) trade information
Instantly TMDX was in red as seen at the end of in last trading. With action -2.69%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 17.08%, with the 5-day performance at -2.69% in the red. However, in the 30-day time frame, Transmedics Group Inc (NASDAQ:TMDX) is 20.03% up.
The consensus price target for the stock as assigned by Wall Street analysts is 109, meaning bulls need an upside of 33.03% from its current market value. According to analyst projections, TMDX’s forecast low is 90 with 125 as the target high. To hit the forecast high, the stock’s price needs a -71.23% plunge from its current level, while the stock would need to soar -23.29% for it to hit the projected low.
Transmedics Group Inc (TMDX) estimates and forecasts
Year-over-year growth is forecast to reach 77.76% up from the last financial year.
Consensus estimates given by 8 financial analysts project the company’s revenue in the current quarter to hit an average of 109.49M. 6 analysts are of the opinion that Transmedics Group Inc’s revenue for the current quarter will be 119.4M. The company’s revenue for the corresponding quarters a year ago was 81.17M and 96.85M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 34.88%. The estimates for the next quarter sales put growth at 23.28%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 8.36%. The 2025 estimates are for Transmedics Group Inc earnings to increase by 227.29%.
TMDX Dividends
Transmedics Group Inc is expected to release its next quarterly earnings report in March.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.0755% or 2.65 million shares worth $398.47 million as of 2024-06-30.
